Balyasny Asset Management
CVS icon

Balyasny Asset Management’s CVS Health CVS Stock Holding History

Balyasny Asset Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17.4M Buy
241,900
+128,800
+114% +$9.92M 0.02% 747
2025
Q4 		$8.98M Sell
113,100
-279,000
-71% -$22M 0.01% 1074
2025
Q3 		$29.6M Buy
392,100
+114,400
+41% +$7.84M 0.04% 547
2025
Q2 		$19.2M Buy
277,700
+99,600
+56% +$6.53M 0.03% 684
2025
Q1 		$12.1M Sell
178,100
-2,200
-1% -$132K 0.02% 815
2024
Q4 		$8.09M Buy
180,300
+127,200
+240% +$7.14M 0.01% 1052
2024
Q3 		$3.34M Sell
53,100
-291,000
-85% -$17M 0.01% 1443
2024
Q2 		$20.3M Buy
344,100
+133,100
+63% +$8.33M 0.04% 597
2024
Q1 		$16.8M Buy
211,000
+200,000
+1,818% +$15.3M 0.03% 702
2023
Q4 		$869K Buy
+11,000
New +$783K ﹤0.01% 1740
2023
Q3 		– Sell
-40,000
Closed -$2.77M – 2333
2023
Q2 		$2.77M Hold
40,000
– – 0.01% 1267
2023
Q1 		$2.97M Sell
40,000
-40,000
-50% -$3.35M 0.01% 1291
2022
Q4 		$7.46M Buy
80,000
+30,000
+60% +$2.89M 0.02% 858
2022
Q3 		$4.77M Hold
50,000
– – 0.01% 1025
2022
Q2 		$4.63M Hold
50,000
– – 0.02% 976
2022
Q1 		$5.06M Buy
+50,000
New +$5.25M 0.02% 940
2021
Q3 		– Sell
-10,000
Closed -$834K – 2019
2021
Q2 		$834K Buy
+10,000
New +$819K ﹤0.01% 1369
2018
Q1 		– Sell
-400,000
Closed -$29M – 2002
2017
Q4 		$29M Buy
+400,000
New +$29.1M 0.09% 301

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Balyasny Asset Management's CVS Position: Q1 2026 in Review

Balyasny Asset Management increased its CVS Health (CVS) stake by 27% in Q1 2026, buying an estimated $19.5M and bringing the position to 1,191,023 shares worth $85.5M. The position accounts for 0.11% of the portfolio, ranked #193.

Balyasny Asset Management first reported a position in CVS in Q4 2013 and has held it in 39 quarters since. The position peaked at $98.1M in Q2 2025. 1,866 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Balyasny Asset Management held 1,191,023 shares of CVS Health worth $85.5M as of Q1 2026.
  • Balyasny Asset Management bought 252,966 CVS Health shares in Q1 2026, an estimated $19.5M.
  • CVS Health made up 0.11% of Balyasny Asset Management's portfolio in Q1 2026, its #193 holding.
  • Balyasny Asset Management first reported a position in CVS Health in Q4 2013 and has held it in 39 quarters since.
  • Balyasny Asset Management's CVS Health position peaked at $98.1M in Q2 2025.
  • 1,866 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.